Cryo-Cell International's (CCEL) Q4 2025 EPS forecast is not currently available. However, we can analyze the company's past trends to provide context.
- Current Q4 2025 EPS Forecast Unavailable: The latest available data on CCEL's EPS is from Q4 2024, which reported $0.08 EPS1. There is no information regarding the Q4 2025 EPS forecast at this time.
- Historical Performance: CCEL's EPS has shown variability over the past few quarters. In Q1 2024, the EPS was $0.07, which was above the analyst estimate of -2 cents2. In Q2 2024, the EPS was $0.08, surpassing the analyst estimate of 4 cents3.
CCEL Diluted EPS YoY, Diluted EPS
- Analyst Ratings and Trends: The overall analyst consensus for CCEL has been positive, with a "Moderate Buy" rating and an average price target of $8.00, indicating potential growth4. However, the success rate for following analysts in the past has been mixed, with some generating profits and others showing no profit4.
- Return on Capital Employed (ROCE): CCEL's ROCE has been negative in the past, indicating potential inefficiencies in capital allocation. An ROCE of -1.12% was reported in Q1 2024, suggesting room for improvement5.
In conclusion, while there is no available data on CCEL's Q4 2025 EPS forecast, the company's recent performance has shown potential for exceeding analyst estimates. However, the lack of available data and the variability of past performance make it challenging to predict future results with certainty. Investors should monitor the company's financial reports and analyst updates for insights into the Q4 2025 EPS forecast.